Limonin inhibits the stemness of cancer stem-like cells derived from colorectal carcinoma cells potentially via blocking STAT3 signaling

CONCLUSION: Taken together, these results indicate that limonin is a promising compound that targets CSCs and could be used to combat CRC recurrence and metastasis.PMID:38455137 | PMC:PMC10915944 | DOI:10.5306/wjco.v15.i2.317

Source: Clinical Colorectal Cancer - March 8, 2024 Category: Cancer & Oncology Authors: Wei-Feng Zhang Cheng-Wei Ruan Jun-Bo Wu Guo-Liang Wu Xiao-Gan Wang Hong-Jin Chen Source Type: research